London, June 6, 2026, 23:02 (BST)
Rentokil Initial plc shares finished Friday mostly flat, but the stock still ended lower for the week. The focus for investors remains on the company’s U.S. recovery, not Friday’s lack of a move.
Rentokil Initial shares ended at 442.40 pence on June 5 in London, with around 7.8 million shares changing hands, according to London Stock Exchange data. The stock edged up 0.07% on Friday after earlier losses, including a 2.01% slide on Monday, historical data showed.
That comes up now since the UK cash market is closed for the weekend, so the next look at demand for the stock will be at Monday’s open. Rentokil slipped 1.43% over the week and is down 10.01% in four weeks, both times worse than the FTSE 350, the London Stock Exchange tearsheet dated June 5 shows.
UK shares saw little support from the market. The FTSE 100 gained 0.07% Friday. Still, Reuters said both the main index and the FTSE 250 ended down for the week while investors weighed risks from the Middle East and inflation.
North America is still the main story for the company. Rentokil’s first-quarter revenue reached $1.68 billion, up 4.3% at constant currency, with organic growth at 3.4%. Revenue in North America rose 4.5% at constant currency to $995 million. Chief Executive Mike Duffy said there was “continued momentum in North America.” Still, group organic growth was a touch under Visible Alpha consensus in the quarter. Morningstar
Rentokil named Rafael “Rafa” Carrasco as the new CEO for North America, effective Aug. 3, the company said on May 21. Carrasco was formerly with WM Healthcare Solutions and Waste Management. CEO Duffy said Carrasco is the “ideal leader to drive our North American business forward.” Carrasco said he plans to focus on “driving operational excellence” and building a “customer-obsessed organisation.” Rentokil Initial
Rollins Inc., which owns Orkin and competes closely with Rentokil in pest control, posted 10.2% revenue growth and 6.6% organic revenue growth for the first quarter in April. That’s ahead of Rentokil’s group pest control and North America pest control growth.
Board changes are on the way at Rentokil. Thérèse Esperdy will take over as chair on Sept. 1, stepping in for Richard Solomons. Solomons said the company has a “clear strategy developed for North American growth.” Esperdy called Rentokil a leading global provider of pest control and hygiene services. Rentokil Initial
No earnings releases are on Rentokil’s calendar for the coming week. The investor page shows interim results scheduled for July 30 and a Q3 trading update on Oct. 22. That puts focus back on trading conditions, what peers do, and belief in the North America plan.
But the risks are out there. Rentokil’s own caution spells out worries like integrating acquisitions, keeping customers, rivals, inflation, supply chain trouble, cyber risk, and lawsuits over termite damage. The company also points to geopolitical uncertainty. If U.S. pest demand, pricing or claims start to slip again, the recent improvement could stall.
LSE data shows the stock is 12.8% under its 52-week high and 31.9% over its 52-week low. Its relative strength index comes in at 31.62. RSI tracks momentum; traders watch levels near 30 as signs of possible oversold conditions, suggesting sellers have pushed the name down but selling isn’t always done at that point.
